Cargando…
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance
BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in western countries, characterized by a heterogeneous clinical course. Although genetic studies have identified chromosomal aberrations or specific mutations, epigenetic changes have been poorly characterized...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141649/ https://www.ncbi.nlm.nih.gov/pubmed/27980696 http://dx.doi.org/10.1186/s13148-016-0298-y |
_version_ | 1782472653696663552 |
---|---|
author | Van Damme, Michaël Crompot, Emerence Meuleman, Nathalie Maerevoet, Marie Mineur, Philippe Bron, Dominique Lagneaux, Laurence Stamatopoulos, Basile |
author_facet | Van Damme, Michaël Crompot, Emerence Meuleman, Nathalie Maerevoet, Marie Mineur, Philippe Bron, Dominique Lagneaux, Laurence Stamatopoulos, Basile |
author_sort | Van Damme, Michaël |
collection | PubMed |
description | BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in western countries, characterized by a heterogeneous clinical course. Although genetic studies have identified chromosomal aberrations or specific mutations, epigenetic changes have been poorly characterized in CLL. METHODS: We assessed ten-eleven translocations (TET) 1, 2, and 3, isocitrate dehydrogenase (IDH) 1, and 2 messenger RNA (mRNA) expression using real-time PCR on purified leukemic B cells from 214 CLL patients (median follow-up = 75 months, range 1–380), normal peripheral blood B cells (n = 20), and umbilical cord blood B cells (n = 21). The microenvironment influence was assessed after 24 h co-culture of CLL cells with bone marrow mesenchymal stromal cells (BMSC). Finally, 5-hydroxymethylcytosine level (%5-hmC) was assessed by ELISA in CLL cells alone or with microenvironment stimuli. RESULTS: TET 1 and 3 and IDH2 were decreased in CLL cells compared with healthy B cells (P = 0.0221, 0.0013, <0.0001, respectively), while IDH1 was overexpressed (P = 0.0037). TET2 and IDH1 were significantly correlated with treatment-free survival (TFS); patients with high TET2/IDH1 expression had a higher median TFS (111 months) than patients with low expression (78 months, P = 0.0071/0.0123). Moreover, TET1 expression decreased (P = 0.0371), while TET3 and IDH2 expression increased (P = 0.0273/0.0039) in co-cultures. However, %5-hmC was not correlated with clinical data and was unchanged following microenvironment stimuli. CONCLUSIONS: Despite a slight deregulation in CLL cells compared with normal B cells, we identified a significant association between TET/IDH gene expression and prognosis, suggesting that epigenetic changes could potentially be associated with disease progression. Moreover, despite an identical %5-hmC, TET gene expression was influenced by contact with BMSC confirming the crucial role of the microenvironment in CLL pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0298-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5141649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51416492016-12-15 Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance Van Damme, Michaël Crompot, Emerence Meuleman, Nathalie Maerevoet, Marie Mineur, Philippe Bron, Dominique Lagneaux, Laurence Stamatopoulos, Basile Clin Epigenetics Research BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in western countries, characterized by a heterogeneous clinical course. Although genetic studies have identified chromosomal aberrations or specific mutations, epigenetic changes have been poorly characterized in CLL. METHODS: We assessed ten-eleven translocations (TET) 1, 2, and 3, isocitrate dehydrogenase (IDH) 1, and 2 messenger RNA (mRNA) expression using real-time PCR on purified leukemic B cells from 214 CLL patients (median follow-up = 75 months, range 1–380), normal peripheral blood B cells (n = 20), and umbilical cord blood B cells (n = 21). The microenvironment influence was assessed after 24 h co-culture of CLL cells with bone marrow mesenchymal stromal cells (BMSC). Finally, 5-hydroxymethylcytosine level (%5-hmC) was assessed by ELISA in CLL cells alone or with microenvironment stimuli. RESULTS: TET 1 and 3 and IDH2 were decreased in CLL cells compared with healthy B cells (P = 0.0221, 0.0013, <0.0001, respectively), while IDH1 was overexpressed (P = 0.0037). TET2 and IDH1 were significantly correlated with treatment-free survival (TFS); patients with high TET2/IDH1 expression had a higher median TFS (111 months) than patients with low expression (78 months, P = 0.0071/0.0123). Moreover, TET1 expression decreased (P = 0.0371), while TET3 and IDH2 expression increased (P = 0.0273/0.0039) in co-cultures. However, %5-hmC was not correlated with clinical data and was unchanged following microenvironment stimuli. CONCLUSIONS: Despite a slight deregulation in CLL cells compared with normal B cells, we identified a significant association between TET/IDH gene expression and prognosis, suggesting that epigenetic changes could potentially be associated with disease progression. Moreover, despite an identical %5-hmC, TET gene expression was influenced by contact with BMSC confirming the crucial role of the microenvironment in CLL pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-016-0298-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-07 /pmc/articles/PMC5141649/ /pubmed/27980696 http://dx.doi.org/10.1186/s13148-016-0298-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Van Damme, Michaël Crompot, Emerence Meuleman, Nathalie Maerevoet, Marie Mineur, Philippe Bron, Dominique Lagneaux, Laurence Stamatopoulos, Basile Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance |
title | Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance |
title_full | Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance |
title_fullStr | Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance |
title_full_unstemmed | Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance |
title_short | Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance |
title_sort | characterization of tet and idh gene expression in chronic lymphocytic leukemia: comparison with normal b cells and prognostic significance |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141649/ https://www.ncbi.nlm.nih.gov/pubmed/27980696 http://dx.doi.org/10.1186/s13148-016-0298-y |
work_keys_str_mv | AT vandammemichael characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance AT crompotemerence characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance AT meulemannathalie characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance AT maerevoetmarie characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance AT mineurphilippe characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance AT brondominique characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance AT lagneauxlaurence characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance AT stamatopoulosbasile characterizationoftetandidhgeneexpressioninchroniclymphocyticleukemiacomparisonwithnormalbcellsandprognosticsignificance |